MedTrace Logo

Omega-3 Fatty Acids in Tourette's Disorder

NCT01315327 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2014-07-01

No results posted yet for this study

Summary

This study examines the safety and efficacy of omega-3 fatty acids (fish oil) for the treatment of Tourette's Disorder.

Conditions

  • Tourette's Disorder

Interventions

DRUG

Omega-3 Fatty Acids

Omega-3 fatty acids (derived from fish oil)

DRUG

Olive oil

Placebo

Sponsors & Collaborators

Principal Investigators

  • Vilma Gabbay, MD, MS · NYU School of Medicine

  • Barbara J Coffey, MD, MS · NYU School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2006-02-28
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01315327 on ClinicalTrials.gov